Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer T Fox

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 19, 2023
Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or VaccinesKonstantin H Dragnev, Ronald A Lubet, Mark Steven Miller, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA ExpressionRonald A Lubet, Amit Kumar, Jennifer T Fox, et al.
Molecular Carcinogenesis|March 20, 2024
Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesisRam Raj Prasad, Neha Mishra, Rama Kant, et al.
Journal of Obesity and Chronic Diseases|April 9, 2021
Effects of High-Fructose Diet <i>vs</i>. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA ExpressionAmit Kumar, Ronald A Lubet, Jennifer T Fox, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2019
Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced CancersRonald A Lubet, Brandy M Heckman-Stoddard, Jennifer T Fox, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell deathJennifer T Fox, Srilatha Sakamuru, Ruili Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2014
ATAD5 deficiency decreases B cell division and Igh recombinationKimberly J Zanotti, Robert W Maul, Diana P Castiblanco, et al.
Cancers|October 28, 2023
Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against <i>TMPRSS2-ERG</i> (Fusion)-Driven and Non-Fusion-Driven Prostate CancerKomal Raina, Kushal Kandhari, Rama Kant, et al.
Molecular Carcinogenesis|April 22, 2022
Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM modelsKomal Raina, Rama Kant, Ram R Prasad, et al.
Cancer Research|June 5, 2016
A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair DeficienciesYongliang Zhang, Jennifer T Fox, Young-Un Park, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|July 19, 2023
Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or VaccinesKonstantin H Dragnev, Ronald A Lubet, Mark Steven Miller, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA ExpressionRonald A Lubet, Amit Kumar, Jennifer T Fox, et al.
Molecular Carcinogenesis|March 20, 2024
Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesisRam Raj Prasad, Neha Mishra, Rama Kant, et al.
Journal of Obesity and Chronic Diseases|April 9, 2021
Effects of High-Fructose Diet <i>vs</i>. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA ExpressionAmit Kumar, Ronald A Lubet, Jennifer T Fox, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2019
Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced CancersRonald A Lubet, Brandy M Heckman-Stoddard, Jennifer T Fox, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell deathJennifer T Fox, Srilatha Sakamuru, Ruili Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2014
ATAD5 deficiency decreases B cell division and Igh recombinationKimberly J Zanotti, Robert W Maul, Diana P Castiblanco, et al.
Cancers|October 28, 2023
Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against <i>TMPRSS2-ERG</i> (Fusion)-Driven and Non-Fusion-Driven Prostate CancerKomal Raina, Kushal Kandhari, Rama Kant, et al.
Molecular Carcinogenesis|April 22, 2022
Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM modelsKomal Raina, Rama Kant, Ram R Prasad, et al.
Cancer Research|June 5, 2016
A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair DeficienciesYongliang Zhang, Jennifer T Fox, Young-Un Park, et al.
Pageof 3